| Primary |
| Product Used For Unknown Indication |
68.0% |
| Prostate Cancer |
24.0% |
| Prostate Cancer Metastatic |
3.8% |
| Pain |
0.9% |
| Neoplasm Prostate |
0.6% |
| Neoplasm Malignant |
0.4% |
| Blood Pressure |
0.4% |
| Nausea |
0.3% |
| Bone Cancer |
0.2% |
| Hypertension |
0.2% |
| Metastases To Bone |
0.2% |
| Anxiety |
0.2% |
| Blood Cholesterol |
0.1% |
| Diabetes Mellitus |
0.1% |
| Metastasis |
0.1% |
| Ill-defined Disorder |
0.1% |
| Sleep Disorder |
0.1% |
| Atrial Fibrillation |
0.1% |
| Chronic Obstructive Pulmonary Disease |
0.1% |
| Insomnia |
0.1% |
|
| Death |
25.9% |
| Malignant Neoplasm Progression |
15.6% |
| Prostatic Specific Antigen Increased |
9.8% |
| Drug Ineffective |
7.8% |
| Fatigue |
7.1% |
| Nausea |
4.4% |
| Weight Decreased |
4.2% |
| Vomiting |
3.5% |
| Hospitalisation |
3.4% |
| Oedema Peripheral |
2.1% |
| Product Size Issue |
2.0% |
| Pain |
1.9% |
| Myalgia |
1.8% |
| Diarrhoea |
1.6% |
| Malaise |
1.6% |
| Hospice Care |
1.5% |
| Incorrect Storage Of Drug |
1.5% |
| Paraesthesia |
1.5% |
| Rash |
1.5% |
| Pain In Extremity |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
68.1% |
| Prostate Cancer |
18.6% |
| Prostate Cancer Metastatic |
4.6% |
| Pain |
2.7% |
| Metastases To Bone |
1.1% |
| Blood Pressure |
0.7% |
| Bone Cancer |
0.5% |
| Neoplasm Prostate |
0.4% |
| Sinus Disorder |
0.4% |
| Colorectal Cancer |
0.3% |
| Deep Vein Thrombosis |
0.3% |
| Gastric Cancer |
0.3% |
| Ill-defined Disorder |
0.3% |
| Prostatomegaly |
0.3% |
| Small Intestine Carcinoma |
0.3% |
| Anxiety |
0.2% |
| Asthenia |
0.2% |
| Atrial Fibrillation |
0.2% |
| Back Pain |
0.2% |
| Bone Disorder |
0.2% |
|
| Somnolence |
12.8% |
| Weight Decreased |
12.8% |
| Nausea |
8.3% |
| Prostatic Specific Antigen Increased |
7.5% |
| Vomiting |
7.5% |
| Fatigue |
6.8% |
| Off Label Use |
6.0% |
| Malignant Neoplasm Progression |
5.3% |
| Drug Ineffective |
4.5% |
| Urinary Tract Infection |
3.8% |
| Oedema Peripheral |
3.0% |
| Pain In Extremity |
3.0% |
| Vertigo |
3.0% |
| Diarrhoea |
2.3% |
| Inappropriate Schedule Of Drug Administration |
2.3% |
| Insomnia |
2.3% |
| Muscle Spasms |
2.3% |
| Paraesthesia |
2.3% |
| Rash |
2.3% |
| Speech Disorder |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.8% |
| Medical Diet |
21.1% |
| Depression |
5.3% |
| Hypertension |
5.3% |
| Prostate Cancer |
5.3% |
| Prostate Cancer Metastatic |
5.3% |
| Cancer Pain |
2.6% |
| Drug Use For Unknown Indication |
2.6% |
| Groin Pain |
2.6% |
| Hip Fracture |
2.6% |
| Hormone Therapy |
2.6% |
| Multiple Myeloma |
2.6% |
| Nephrolithiasis |
2.6% |
| Osteoporosis Prophylaxis |
2.6% |
|
| Death |
20.0% |
| Malaise |
20.0% |
| Neoplasm |
20.0% |
| Plasma Cell Myeloma |
20.0% |
| Prostate Cancer Metastatic |
20.0% |
|
| Interacting |
| Product Used For Unknown Indication |
45.8% |
| Prostate Cancer Metastatic |
20.8% |
| Cancer Pain |
16.7% |
| Oedema Peripheral |
4.2% |
| Pain |
4.2% |
| Prostate Cancer |
4.2% |
| Prostatomegaly |
4.2% |
|
| Vomiting |
50.0% |
| Immune System Disorder |
25.0% |
| Unevaluable Event |
25.0% |
|
